1. Home
  2. GRI vs TOPS Comparison

GRI vs TOPS Comparison

Compare GRI & TOPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$1.99

Market Cap

4.5M

Sector

Health Care

ML Signal

HOLD

Logo TOP Ships Inc.

TOPS

TOP Ships Inc.

HOLD

Current Price

$0.73

Market Cap

4.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRI
TOPS
Founded
2018
2000
Country
United States
Greece
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.9M
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
GRI
TOPS
Price
$1.99
$0.73
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$160.00
N/A
AVG Volume (30 Days)
817.2K
97.8K
Earning Date
05-15-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.14
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.62
52 Week High
$6.70
$7.40

Technical Indicators

Market Signals
Indicator
GRI
TOPS
Relative Strength Index (RSI) 51.80 39.77
Support Level $0.20 $0.70
Resistance Level $2.53 $0.87
Average True Range (ATR) 0.28 0.05
MACD 0.06 -0.01
Stochastic Oscillator 21.06 5.40

Price Performance

Historical Comparison
GRI
TOPS

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About TOPS TOP Ships Inc.

TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco-tanker vessels, focusing on the transportation of crude oil, petroleum products (both clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements. The company operates in two reportable segments: (i) the tanker segment and (ii) the megayacht segment.

Share on Social Networks: